Imbruvica Market, By Indication (Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) With 17p Deletion, Waldenstrom’s macroglobulinemia (WM), and Chronic Graft Versus Host Disease (cGVHD)), By Dosage Form and Strength (Capsules (70 mg and 140 mg), Tablets (140 mg, 280 mg, and 420 mg), and Suspension (70 mg/mL)), By Age Group (Pediatric and Adult), By End User (Hospitals, Specialty Oncology Clinics, Outpatient cancer centers, Specialty Pharmacies, and Others (Research and Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
US$ 3,000
Three thousand dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
US$ 5,000
Five thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
우리의 고객